ArticleBiomedical microdevices2026
Assessment of physicochemical alterations in 3D-printed biodegradable implants under biomimetic conditions for cranial defect repair.
Article in Biomedical microdevices, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding Polycaprolactone Degradation: Molecular Mechanisms and Implications for Biomedical Device Design.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Once implanted, biodegradable devices gradually deteriorate, potentially compromising clinical performance. Consequently, evaluating the alterations in physicochemical characteristics after implantation is crucial. Nonetheless, there is currently no established methodology for precisely assessing these alterations. This study sought to develop accurately simulated cranial defect physiological conditions (SCDPC) and examine the physicochemical modifications in biodegradable cranioplasty plates (BCP) to anticipate their performance changes following implantation in humans. We analyzed the physicochemical property alterations of BCP following 24 weeks of exposure to SCDPC. Following 24 weeks under SCDPC, the BCP showed a notable reduction in mass (- 0.79%) and tensile strength (- 69.30%). A decrease in molecular weight was noted after 12 weeks of implantation in rabbits (- 9.67%) and following 12 weeks of exposure to SCDPC (- 4.73%). The physicochemical alterations identified under simulated in vitro cranial defect conditions closely mirrored those found in the in vivo setting. In summary, assessing BCP under SCDPC offers an innovative and dependable approach for precisely forecasting performance shifts after implantation. This strategy could provide meaningful guidance for the advancement of BCP and various other biodegradable medical devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.